CARLA GILBERT: Open Payments
NPI 1669021523 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 48 payments from 18 companies in 2025. Trend: 2023 $1,945 · 2024 $737 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 15 | $234 |
| Novo Nordisk Inc | 6 | $108 |
| Sumitomo Pharma America, Inc. | 5 | $82 |
| Boston Scientific Corporation | 3 | $53 |
| ConvaTec Inc. | 1 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Verona Pharma, Inc. | 2 | $38 |
| Astellas Pharma US Inc | 2 | $34 |
| ABBVIE INC. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
Products named: VOQUEZNA, Rybelsus, GEMTESA, CURE ULTRA CATHETER, Kerendia, Ohtuvayre, Veozah, FARXIGA.
Industry payments across KY — which companies pay providers there.
